Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionSummit Global Investments
Latest Disclosed Ownership26,658 shares
Latest Disclosed Value $ 1,617
Summit Global Investments reports 7.07% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 7, 2026 - Summit Global Investments filed a 13F-HR form disclosing ownership of 26,658 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,397,412 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 24,897 shares of Bristol-Myers Squibb Company. This represents a change in shares of 7.07% during the quarter. The current value of the position is $1,264,389 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 26,658 1,761 7.07 2 0.00 0.0954
2026-02-17 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 24,897 6,964 38.83 1 0.0794
2025-11-03 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,933 17,933 1 0.0473
2025-04-07 2025-03-31 13F BRISTOL-MYERS SQUIBB CO C OM 110122108 0 -11,680 -100.00 0 0.0000
2025-02-11 2024-12-31 13F BRISTOL-MYERS SQUIBB CO C OM 110122108 11,680 -15,685 -57.32 1 -100.00 0.0414
2024-10-31 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 27,365 -35,829 -56.70 1 -50.00 0.0903
2024-07-22 2024-06-30 13F BRISTOL-MYERS SQUIBB CO C OM 110122108 63,194 33,359 111.81 3 100.00 0.1770
2024-04-29 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 29,835 -8,205 -21.57 2 0.00 0.1203
2024-02-06 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 38,040 -133,210 -77.79 2 -88.89 0.1278
2023-10-16 2023-09-30 13F BRISTOL-MYERS SQUIBB CO C OM 110122108 171,250 -90,096 -34.47 10 -43.75 0.6619
2023-07-19 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 261,346 17,946 7.37 17 0.00 1.1064
2023-05-04 2023-03-31 13F BRISTOL-MYERS SQUIBB CO C OM 110122108 243,400 6,296 2.66 17 -5.88 1.3049
2023-01-31 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 237,104 -1,768 -0.74 17 -99.90 1.4398
2022-11-14 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 238,872 -21,063 -8.10 16,981 -15.16 1.5703
2022-08-23 2022-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 259,935 -13,100 -4.80 20,015 0.38 1.7631
2022-04-29 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 273,035 -65,419 -19.33 19,940 -5.51 1.4696
2022-02-14 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 338,454 304,828 906.52 21,103 960.45 1.3545
2021-11-08 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 33,626 -1,189 -3.42 1,990 -14.19 0.1492
2022-01-28 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 34,815 -8,479 -19.58 2,319 -15.15 0.1388
2022-01-27 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 43,294 -504 -1.15 2,733 0.59 0.1751
2021-02-11 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 43,798 2,299 5.54 2,717 8.59 0.2715
2020-11-16 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 41,499 -4,517 -9.82 2,502 -7.54 0.2585
2020-08-11 2020-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 46,016 26,075 130.76 2,706 143.35 0.3122
2020-05-14 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 19,941 -189,716 -90.49 1,112 -91.74 0.1621
2020-02-13 2019-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 209,657 -105,246 -33.42 13,458 -15.72 1.4591
2019-11-08 2019-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 314,903 -66,494 -17.43 15,969 -7.67 1.8559
2019-08-16 2019-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 381,397 142,532 59.67 17,296 51.77 2.1753
2019-05-14 2019-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 238,865 9,965 4.35 11,396 -4.22 1.4545
2019-02-08 2018-12-31 13F Bristol-Myers Squibb COM 110122108 228,900 208,335 1,013.06 11,898 831.71 1.8430
2018-11-14 2018-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,565 -10 -0.05 1,277 12.12 0.1715
2018-08-10 2018-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,575 12,265 147.59 1,139 116.54 0.1718
2018-05-03 2018-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,310 8,310 526 0.0837
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.